Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

被引:360
作者
Snoek-van Beurden, PAM [1 ]
Von den Hoff, JW [1 ]
机构
[1] Univ Med Ctr Nijmegen, Dept Orthodont & Oral Biol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.2144/05381RV01
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The balance between matrix metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMps), is largely responsible for the remodeling of tissues. Deregulation of this balance is a characteristic of extensive tissue degradation in certain degenerative diseases. To analyze the role of MMPs and TIMPs in tissue remodeling under normal and pathological conditions, it is important to have reliable detection methods. This review will focus on zymographical techniques for the analysis of MMPs and TIMPs. MMPs can be analyzed with several zymographical techniques, but substrate zymography is the most commonly used. This technique identifies MMPs by the degradation of their preferential substrate and by their molecular weight. Several substrates that can be used for zymography are described. Reverse zymography, which detects TIMPs by their ability to inhibit MMPs, is also discussed. Finally, in situ zymography is described, which is used to localize MMPs in tissue sections. Common problems encountered during sample preparation, zymography itself and the data analysis are discussed. Hints are given to improve the sensitivity and accuracy of zymographical methods. In conclusion, zymography is a valuable tool for research purposes and for the development of new diagnostic techniques and therapies for pathological conditions such as rheumatoid and osteoarthritis, and tumor progression.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 89 条
[1]   Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer [J].
Ahokas, K ;
Lohi, J ;
Lohi, H ;
Elomaa, O ;
Karjalainen-Lindsberg, ML ;
Kere, J ;
Saarialho-Kere, U .
GENE, 2002, 301 (1-2) :31-41
[2]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[3]   Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[4]  
Bjornland K, 1999, CANCER RES, V59, P4702
[5]   Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases [J].
Bode, W ;
Maskos, K .
BIOLOGICAL CHEMISTRY, 2003, 384 (06) :863-872
[6]   A HELPING HAND FOR COLLAGENASES - THE HEMOPEXIN-LIKE DOMAIN [J].
BODE, W .
STRUCTURE, 1995, 3 (06) :527-530
[7]   Insights into MMP-TIMP interactions [J].
Bode, W ;
Fernandez-Catalan, C ;
Grams, F ;
Gomis-Rüth, FX ;
Nagase, H ;
Tschesche, H ;
Maskos, K .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :73-91
[8]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[9]   Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model [J].
Bremer, C ;
Bredow, S ;
Mahmood, U ;
Weissleder, R ;
Tung, CH .
RADIOLOGY, 2001, 221 (02) :523-529
[10]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283